SiteMap
Jiuyuan Gene
With innovation as the guide,and market as the support
build a leading biopharmaceutical company
A high and new technology company, specialized in R&D,manufacture and sales of
biopharmaceuticals and medical devices.
Jiuyuan Gene
Taking gene engineering as orientation
Rendering service to human health
A high and new technology company, specialized in R&D,manufacture and sales of
biopharmaceuticals and medical devices.
Jiuyuan Gene
ABOUT US
Jiuyuan Gene
Taking gene engineering as orientation,
Rendering service to human health

Hangzhou Jiuyuan Gene Engineering Co., Ltd.(2566.HK) is a high and new technology company, specialized in R&D,manufacture and sales of biopharmaceuticals and medical devices. We focus on four rapidly growing therapeutic areas: orthopedics, metabolic diseases, oncology and hematology. The company was established in December 1993 and is one of the earliest gene engineering pharmaceutical companies in Zhejiang Province and even in the whole country.


The company always upholds the concept “Taking gene engineering as orientation, Rendering service to human health”, to pursue innovation and to strive for excellence. In October 1996, the company took the lead in successful development and industrialization.....

Product Center

PRODUCT CENTER

Hangzhou Jiuyuan Gene Engineering Co., Ltd. has actively propelled the progress of biopharmaceutical industrialization, gradually developed a series of products including JILIFEN, JIPAILIN, JIJUFEN, YINUOJIA, JIOUTING and GUYOUDAO.

DRUG CLASS
DRUG CLASS
DRUG CLASS
Actively propel the progress of biopharmaceutical industrialization, gradually developed a series of products including JILIFEN, JIPAILIN, JIJUFEN, YINUOJIA, JIOUTING.
MEDICAL DEVICE
MEDICAL DEVICE
MEDICAL DEVICE
Bone repairing material, the only quantitative rhBMP-2 bone repairing material in China, a new generation of genetically engineered bone repairing material.
NEWS CENTER
JIUYUAN NEWS
Jiuyuan Gene
HISTORY
DEVELOPMENT HISTORY
HISTORY
DEVELOPMENT HISTORY
  • 1993.
    Our company was registered and established in December.
  • 1996.
    Our company lanuched the frist product JLIFEN(Filgrastim) in October.
  • 1997.
    Our company obtained NDA approval for JIPAILIN(Low molecular weight heparin sodium injection) in June.
  • 2003.
    Our company obtained NDA approval for JIJUFEN(Human interleukin-11 for injection) in September.
  • 2006.
    Our company obtained NDA approval for YINUOJIA(Enoxaparin sodium injection) in July.
  • 2008.
    Our company was rated as a national High and New tech enterprise.
  • 2009.
    Our company obtained NDA approval for GUYOUDAO(BMP-2).
  • 2011.
    Our company established the Hangzhou Academician Expert Workstation.
  • 2022.
    Our company obtained NDA approval for JIFUWEI(Fulvestrant injection).
  • 2023.
    Our company obtained NDA approval for JITANSU(Fosaprepitant dimeglumine for injection).
    Our company obtained NDA approval for Liraglutide.
  • 2024.
    Our company's biosimilar semaglutide was the first company to apply for production license in China.